Professor Lai-Ming Ching obtained her BSc, MSc (Hons), and PhD in Cell Biology all from The University of Auckland. Following a period after graduation at the Ontario Cancer Institute in Toronto, and The University of Washington in Seattle, she returned to New Zealand to a position at the Auckland Cancer Society Research Centre to investigate the mode of action of novel drugs developed at the Centre. She currently leads the Stromal Targeting Group at the Centre.
Prof Ching has a background in immunology, and now specializes on the development of agents that activate the cells of the immune system that have infiltrated into the tumour. Prof Ching has over 100 publications and 7 patents in this area of cancer research.